Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan (Q24813346)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan	scientific article

Statements

scholarly article

0 references

Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan (English)

0 references

immunohistochemistry

1 reference

based on heuristic

inferred from title

Erb-b2 receptor tyrosine kinase 2

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

breast carcinoma

1 reference

based on heuristic

inferred from title

author name string

Nidal M Almasri

1

0 references

Mohammad Al Hamad

2

0 references

language of work or name

0 references

publication date

2005

0 references

Breast Cancer Research

0 references

7

0 references

5

0 references

R598-604

0 references

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

7 April 2017

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

7 April 2017

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

7 April 2017

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

7 April 2017

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

7 April 2017

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

7 April 2017

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

7 April 2017

Age-associated biomarker profiles of human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

Trastuzumab/chemotherapy combinations in metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

Smart drugs: tyrosine kinase inhibitors in cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

Engineered antibodies take center stage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

Overview of treatment results with trastuzumab (Herceptin) in metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

Immunohistochemical expression of p53 and c-erbB2 proteins in breast cancer in Egypt

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

Evaluation of HER-2/neu (erbB-2) status in breast cancer: from bench to bedside

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

The type I growth factor receptors in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

The neu-protein and breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

Estrogen and progesterone receptors in human breast cancer. Correlation with histologic subtype and degree of differentiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

Human breast cancer: identification of populations with a high risk of early relapse in relation to both oestrogen receptor status and c-erbB-2 overexpression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1242123

28 September 2017

Determination of HER-2 status and chromosome 17 polysomy in breast carcinomas comparing HercepTest and PathVysion FISH assay.

1 reference

https://api.crossref.org/works/10.1186%2FBCR1200

21 January 2018

A comparison of five immunohistochemical biomarkers and HER‐2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early‐onset breast carcinoma

1 reference

https://api.crossref.org/works/10.1186%2FBCR1200

21 January 2018

Do we need HER-2/neu testing for all patients with primary breast carcinoma?

1 reference

https://api.crossref.org/works/10.1186%2FBCR1200

21 January 2018

Biologic significance of quantitative estrogen receptor immunohistochemical assay by image analysis in breast cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR1200

21 January 2018

Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database

1 reference

https://api.crossref.org/works/10.1186%2FBCR1200

21 January 2018

[Relationship of C-erbB-2 oncogene overexpression to estrogen progesterone receptors in brease cancer and its prognostic significance]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Breast carcinoma: evaluation of hormone receptors and pS2, erb-B2, P-glycoprotein and Ki-67 markers]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of HER-2/neu oncogene amplification detected by fluorescence in situ hybridization in lobular and ductal breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER2/neu amplification in breast cancer: stratification by tumor type and grade

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast diseases in Jordanian females: a study of 1000 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A study of 405 breast tumors in Jordanians using the Revised WHO classification

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of immunocytochemically demonstrated estrogen receptor distribution and histopathologic features in primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer patterns in Jordan 1975-1979

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-ERBB-2 oncogens protein inIn situ and invasive lobular breast neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oestrogen receptor analysis of paraffin sections and cytosol samples of primary breast cancer in relation to outcome after adjuvant tamoxifen treatment. The South Sweden Breast Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical detection of c-erbB-2 oncoprotein in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERBB2 oncogene in human breast cancer and its clinical significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue heterogeneity of immunohistochemically detected estrogen receptor. Implications for image analysis quantification

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen and progesterone receptor concentrations and prevalence of tumor hormonal phenotypes in older breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16168103

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/BCR1200

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24813346&oldid=2175281622"